Ertapenem
Kathryn Dzintars, Pharm.D., BCPS
,
Edina Avdic, Pharm.D.
INDICATIONS
INDICATIONS
INDICATIONS
FDA
FDA
FDA
Complicated intra-abdominal infections
Community-acquired pneumonia
(
CAP
)
Complicated urinary tract infections
Complicated skin and skin structure infections, including
diabetic foot infections
without osteomyelitis
Elective colorectal
surgical prophylaxis
Acute pelvic infections (postpartum, septic abortion, and post-surgical gynecologic infections)
Ertapenem is FDA-indicated in pediatrics (3 months-17 yo) for the above indications.
NON-FDA APPROVED USES
NON-FDA APPROVED USES
NON-FDA APPROVED USES
Mild-moderate
intra-abdominal infections
(
cholecystitis
,
cholangitis
,
diverticulitis
,
splenic
and
hepatic abscesses
,
peritonitis
)
Uncomplicated ESBL infections (e.g., UTIs, biliary tract infections)
There's more to see -- the rest of this topic is available only to subscribers.
© 2000–2025 Unbound Medicine, Inc. All rights reserved